Form 4: Ardelvx CEO Michael Raab Reports Stock Sale to Cover Taxes After RSU Vesting
SEC Form 4 Filing
Michael Raab, CEO of Ardelyx, Inc., reports the sale of shares to cover withholding taxes upon the vesting of restricted stock units, along with adjustments to beneficial ownership.
Summary
- On May 21, 2024, Michael Raab, the President and CEO of Ardelyx, Inc., sold 31,484 shares of common stock at a price of $7.811 per share.
- This sale was executed automatically to cover applicable withholding taxes upon the vesting of restricted stock units (RSUs).
- Following the transaction, Raab directly owns 1,277,773 shares of Ardelyx common stock.
- Raab also indirectly owns 24,364 shares through a family trust and 1,000 shares through trusts for the benefit of his children.
- The reported total includes the purchase of 1,324 shares under the Ardelyx Employee Stock Purchase Plan in February 2024.
Sentiment
Score: 5
Explanation: Neutral sentiment as the document primarily reports a routine stock sale for tax purposes, with no indication of significant positive or negative implications.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in compliance with SEC regulations.
- Executive stock sales to cover taxes upon RSU vesting are a common occurrence across various industries.
- The level of detail provided in this filing is consistent with industry norms for transparency.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders due to the increased supply of shares, but it is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| July 25, 2012 | Date of the Michael G. Raab Living Trust |
| February 2024 | Purchase of 1,324 shares under the Ardelyx Employee Stock Purchase Plan |
| 05/21/2024 | Date of stock sale transaction |
| 05/23/2024 | Date of signature by Attorney-in-Fact |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.